101 related articles for article (PubMed ID: 6940654)
1. Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cells.
Akman SA; Ross DD; Rosen H; Salinger C; Andrews PA; Chou FE; Bachur NR
Cancer Res; 1981 Jun; 41(6):2141-6. PubMed ID: 6940654
[TBL] [Abstract][Full Text] [Related]
2. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
3. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
Ross DD; Akman SA; Schrecker AW; Bachur NR
Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
[TBL] [Abstract][Full Text] [Related]
4. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
Keoffler HP; Yen J; Carlson J
J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
[TBL] [Abstract][Full Text] [Related]
5. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
6. Preferential growth inhibition of human leukemic versus normal myeloid colony-forming cells by 12-O-tetradecanoylphorbol-13-acetate.
Park CH
Exp Hematol; 1984 Jun; 12(5):285-90. PubMed ID: 6723821
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT; Regazzi E; Garau D; Akard L; Dugan M; Boswell HS; Rizzoli V; Carlo-Stella C
Cancer Res; 1999 Oct; 59(19):5047-53. PubMed ID: 10519422
[TBL] [Abstract][Full Text] [Related]
8. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
Yu J; Batova A; Shao L; Carrera CJ; Yu AL
Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
[TBL] [Abstract][Full Text] [Related]
9. Clonal growth of human acute myeloid leukemia cells (ML-1 and HL-60) in serum-free agar medium.
Taketazu F; Kubota K; Kajigaya S; Shionoya S; Motoyoshi K; Saito M; Takaku F; Miura Y
Cancer Res; 1984 Feb; 44(2):531-5. PubMed ID: 6607105
[TBL] [Abstract][Full Text] [Related]
10. Effects of partially thiolated polycytidylic acid on the clonogenicity of murine leukemic stem cells.
Ho YK; Preisler HD; Bardos TJ
Cancer Res; 1979 Aug; 39(8):3163-6. PubMed ID: 287552
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
Somekh E; Douer D; Shaked N; Rubinstein E
J Pharmacol Exp Ther; 1989 Jan; 248(1):415-8. PubMed ID: 2913285
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.
Bendall LJ; Daniel A; Kortlepel K; Gottlieb DJ
Exp Hematol; 1994 Dec; 22(13):1252-60. PubMed ID: 7957711
[TBL] [Abstract][Full Text] [Related]
13. Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow.
Koeffler HP; Lowe L; Golde DW
Cancer Treat Rep; 1980 Jan; 64(1):105-9. PubMed ID: 6929726
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic susceptibility of human bone marrow progenitor cells and human myelogenous leukemia cells (HL-60) in co-culture: preliminary report.
Himori T; Ohnuma T; Holland JF
Int J Cell Cloning; 1984 Jul; 2(4):254-62. PubMed ID: 6589302
[TBL] [Abstract][Full Text] [Related]
15. Trophoblast cell line conditioned medium for in vitro culture and antigenic characterization of acute myeloid leukemia clonogenic cells.
Ferrero D; Pregno P; Tarella C; Ruscetti FW; Pileri A; Gallo E
Cancer Res; 1987 Dec; 47(23):6413-7. PubMed ID: 3499973
[TBL] [Abstract][Full Text] [Related]
16. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
17. Human bone marrow fibroblastic cells can inhibit clonogenic growth of K562 cells.
Noguchi K; Nagao T; Arimori S
Tokai J Exp Clin Med; 1985 Oct; 10(5):537-43. PubMed ID: 3870061
[TBL] [Abstract][Full Text] [Related]
18. Extensive proliferative capacity of single isolated CD34 human cord blood cells in suspension culture.
Xiao M; Broxmeyer HE; Horie M; Grigsby S; Lu L
Blood Cells; 1994; 20(2-3):455-66; discussion 466-7. PubMed ID: 7538351
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
20. Growth suppression of human leukemic cells in vitro by L-ascorbic acid.
Park CH; Amare M; Savin MA; Hoogstraten B
Cancer Res; 1980 Apr; 40(4):1062-5. PubMed ID: 6928398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
